ABIOMED, Inc. (NASDAQ:ABMD)

CAPS Rating: 5 out of 5

The Company is a provider of medical devices in circulatory support and offer a continuum of care in heart recovery to acute heart failure patients.

Results 1 - 12 of 12

Recs

0
Member Avatar racoveanul (78.84) Submitted: 4/12/2014 3:05:27 PM : Outperform Start Price: $23.81 ABMD Score: +21.20

ABMD has an A for financial health and a PEG less than 1 on Morningstar, so it's one of my long picks.

Recs

0
Member Avatar SamsaricSufferer (< 20) Submitted: 2/27/2013 9:12:30 AM : Outperform Start Price: $15.57 ABMD Score: +66.08

Recent FDA investigation resolved without penalties. Continuing growth in device sales. Nothing has changed fundamentally since it was beaten down 30% by the now resolved FDA inquiry.

Recs

0
Member Avatar eldomador1 (< 20) Submitted: 3/8/2012 1:55:51 AM : Outperform Start Price: $20.93 ABMD Score: +2.07

It saves lives, it cheaper than the alternative, and the company is well run.

Recs

0
Member Avatar HardnoseDotCom (69.90) Submitted: 4/25/2011 1:35:11 PM : Outperform Start Price: $16.31 ABMD Score: +40.85

low PEG, strong price uptrend

Recs

0
Member Avatar pyupie0216 (< 20) Submitted: 8/18/2010 5:53:14 PM : Underperform Start Price: $9.71 ABMD Score: -136.71

screener

Recs

0
Member Avatar Displacement (< 20) Submitted: 9/16/2009 10:40:13 PM : Outperform Start Price: $8.94 ABMD Score: +159.83

I really like these technicals and if it gets some volume and starts breaking its resistance around $9 I can see it going to 11 or 12. We'll see, it's a maybe.

Recs

1
Member Avatar ScreenerStizBear (77.03) Submitted: 6/26/2008 2:26:22 PM : Underperform Start Price: $18.47 ABMD Score: -8.38

I simply used the screener to identify 1-star companies with the highest 52-week gain. The 1-star rating should mean they are bad companies and the 52-week gain should mean they are overpriced. We’ll see how it works!

Recs

1
Member Avatar dlee210 (< 20) Submitted: 6/24/2008 5:41:09 PM : Outperform Start Price: $18.01 ABMD Score: +15.95

Has the first total transplantable artificial heart. This company has the innovation to create more medical products that will soon be approved and used.

Recs

1
Member Avatar Sqwii (< 20) Submitted: 6/16/2008 10:56:05 AM : Outperform Start Price: $18.98 ABMD Score: +11.82

short term pick, equity nr. 2 list

Recs

0
Member Avatar LetterA (65.27) Submitted: 4/6/2008 3:01:41 AM : Outperform Start Price: $13.50 ABMD Score: +79.70

Testing a portfolio of companies that start with the letter "A".

Recs

0
Member Avatar samlove (21.09) Submitted: 1/2/2008 1:52:55 PM : Outperform Start Price: $15.46 ABMD Score: +56.89

On a strictly technical basis, my magic charts say this will outperform the S&P

Recs

0
Member Avatar whansard (< 20) Submitted: 12/4/2006 4:55:37 PM : Outperform Start Price: $12.75 ABMD Score: +92.31

I like it

Results 1 - 12 of 12

Featured Broker Partners


Advertisement